These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 9204201)

  • 1. Somatostatin analogs and receptors. Diagnostic and therapeutic applications.
    Hofland LJ; Lamberts SW
    Cancer Treat Res; 1997; 89():365-82. PubMed ID: 9204201
    [No Abstract]   [Full Text] [Related]  

  • 2. Structure and function of somatostatin receptors in growth hormone control.
    Shimon I; Melmed S
    J Endocrinol; 1997 Oct; 155 Suppl 1():S3-6; discussion S7-8. PubMed ID: 9389989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatostatin analogs for diagnosis and treatment of cancer.
    Weckbecker G; Raulf F; Stolz B; Bruns C
    Pharmacol Ther; 1993 Nov; 60(2):245-64. PubMed ID: 7912834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatostatin receptors in non-neuroendocrine malignancies: the potential role of somatostatin analogs in solid tumors.
    Hasskarl J; Kaufmann M; Schmid HA
    Future Oncol; 2011 Jul; 7(7):895-913. PubMed ID: 21732759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of somatostatin and its analogs in the diagnosis and treatment of tumors.
    Lamberts SW; Krenning EP; Reubi JC
    Endocr Rev; 1991 Nov; 12(4):450-82. PubMed ID: 1684746
    [No Abstract]   [Full Text] [Related]  

  • 6. [Somatostatin receptors and its analogs in diagnosis and treatment of human tumors].
    Raĭkhlin NT; Smirnova EA; Delektroskaia VV
    Vopr Onkol; 2010; 56(1):7-13. PubMed ID: 20361608
    [No Abstract]   [Full Text] [Related]  

  • 7. Biology of somatostatin in breast cancer.
    Watt HL; Kharmate G; Kumar U
    Mol Cell Endocrinol; 2008 May; 286(1-2):251-61. PubMed ID: 18308465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatostatin analogs: clinical application in relation to human somatostatin receptor subtypes.
    Hofland LJ; Visser-Wisselaar HA; Lamberts SW
    Biochem Pharmacol; 1995 Jul; 50(3):287-97. PubMed ID: 7646531
    [No Abstract]   [Full Text] [Related]  

  • 9. Somatostatin analogs in the treatment of neuroendocrine tumors: current and emerging aspects.
    Mazziotti G; Mosca A; Frara S; Vitale G; Giustina A
    Expert Opin Pharmacother; 2017 Nov; 18(16):1679-1689. PubMed ID: 29067877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pasireotide in the treatment of neuroendocrine tumors: a review of the literature.
    Vitale G; Dicitore A; Sciammarella C; Di Molfetta S; Rubino M; Faggiano A; Colao A
    Endocr Relat Cancer; 2018 Jun; 25(6):R351-R364. PubMed ID: 29643113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-world approaches for extending progression-free survival in patients with metastatic pancreatic neuroendocrine tumors: focus on timing, sequencing, regimen initiation, and maintenance strategies using somatostatin analogs, targeted agents, and peptide receptor radiotherapy.
    Wolin EM
    Clin Adv Hematol Oncol; 2018 Sep; 16 Suppl 17(9):11-14. PubMed ID: 30807563
    [No Abstract]   [Full Text] [Related]  

  • 12. Diagnostic reliability of somatostatin receptor scintigraphy during continuous treatment with different somatostatin analogs.
    Dörr U; Wurm K; Höring E; Guzman G; Räth U; Bihl H
    Horm Metab Res Suppl; 1993; 27():36-43. PubMed ID: 8330870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatostatin analogs for the treatment of neuroendocrine tumors.
    Culler MD; Oberg K; Arnold R; Krenning EP; Sevilla I; Díaz JA
    Cancer Metastasis Rev; 2011 Mar; 30 Suppl 1():9-17. PubMed ID: 21369878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New somatostatin analogs: will they fulfil old promises?
    Lamberts SW; van der Lely AJ; Hofland LJ
    Eur J Endocrinol; 2002 May; 146(5):701-5. PubMed ID: 11980627
    [No Abstract]   [Full Text] [Related]  

  • 15. Physiology of somatostatin receptors.
    Guillermet-Guibert J; Lahlou H; Cordelier P; Bousquet C; Pyronnet S; Susini C
    J Endocrinol Invest; 2005; 28(11 Suppl International):5-9. PubMed ID: 16625838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of somatostatin analogs in the control of tumor growth.
    Lamberts SW; Reubi JC; Krenning EP
    Semin Oncol; 1994 Oct; 21(5 Suppl 13):61-4. PubMed ID: 7992085
    [No Abstract]   [Full Text] [Related]  

  • 17. Potential indications for somatostatin analogs in Cushing's syndrome.
    Arnaldi G; Polenta B; Cardinaletti M; Boscaro M
    J Endocrinol Invest; 2005; 28(11 Suppl International):106-10. PubMed ID: 16625858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatostatin receptor physiology and targets for somatostatin analogue therapy. Abstracts of the Young Investigators' Meeting. 28-30 January 2005, Barcelona, Spain.
    Eur J Endocrinol; 2005 Feb; 152 Suppl 1():60 pages. PubMed ID: 15825261
    [No Abstract]   [Full Text] [Related]  

  • 19. Somatostatin analogs in acromegaly.
    Freda PU
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3013-8. PubMed ID: 12107192
    [No Abstract]   [Full Text] [Related]  

  • 20. [Somatostatin analogs in the treatment of pancreatic cancer: utopia or feasible alternative?].
    Zalatnai A; Pogány V
    Orv Hetil; 2000 Oct; 141(43):2333-8. PubMed ID: 11089387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.